When the global clinical trial industry was suddenly forced to adapt to unprecedented challenges, traditional trial conduct models were upended. Some trials were delayed or even cancelled. Yet other trials thrived and still more were able to restart after adopting decentralized clinical trial (DCT) methodologies.
In this educational webinar, speakers will review recent case studies and walk through several unique situations from the last seven months. From changing inflight studies to creating entirely new studies, several thought leaders will share their experiences with DCT approaches and how they contributed to trial continuity and increased the resilience of trials.
From technology platforms to home health care services and mobile devices, attendees will learn how several new DCT solutions are being applied to sponsor’s trial needs, and how sponsor needs are directing the evolution of these flexible services in real time. Join our featured speakers to understand the ongoing evolution of trial models to become more efficient, more convenient and better able to adapt to the changing world.
Bola Oyegunwa, Vice President & Head of Decentralized Clinical Trials, Covance
Bola Oyegunwa is an industry thought leader in developing and implementing decentralized clinical trial solutions. He is a champion for reducing patient burden in clinical trials and led the implementation of innovative technology-enabled decentralized clinical trials solutions for leading Biotech and pharmaceutical companies. Oyegunwa has been a strategy consultant with leadership roles in corporate strategy, product development and innovation at leading CROs, and he regularly engages with regulatory authorities to remove regulatory barriers to the adoption of virtual clinical trials.Message Presenter
Gail Adinamis, Chief Executive Officer, GlobalCare Clinical Trials, LLC
Gail Adinamis is founder and CEO of GlobalCare Clinical Trials, LLC, a global patient-centric service organization that conducts study visits at patients’ homes or alternate settings via a global network of mobile healthcare providers to support traditional, virtual or hybrid clinical studies. Adinamis has 40 years of comprehensive global clinical trials experience including over 12 years of global trials management at Abbott Laboratories and Astellas Pharma US. Adinamis is active in many industry associations and has been an invited speaker at several industry conferences and recipient of numerous awards and recognitions.Message Presenter
Joan Meyer, PhD, Executive Director, Inflammation, Infectious Disease & General Medicine, Covance
Dr. Joan Meyer has over 30 years Research and Clinical development experience. She spent 23 years at Procter & Gamble, 10 years of basic research and 13 in clinical development. Dr. Meyer has 12 years of CRO experience in a variety of roles including project management, strategic marketing, study start-up and strategy & planning. Dr. Meyer has designed and/or led clinical studies in a variety in indications across many therapeutic areas including rheumatology, respiratory, gastroenterology, infectious disease, women and men’s health, dermatology, urology, and pain. Dr. Meyer received her PhD in Neuroscience from the University of Illinois.Message Presenter
Christian Knaus, Senior Director, Client Development, SnapIoT, Inc.
Christian Knaus has worked globally in clinical trials since 2006. At what was then known as VIASYS Clinical Research (now ERT) he accrued his first acumen in the respiratory field as a project manager producing spirometry solutions as well as ePRO devices with PEF-Meters for clinicians as well as patient home monitoring and adding cardiac safety and all things eCOA to his experience portfolio over the years. Since 2016, Knaus has spearheaded the path toward paperless clinical trials including eCOA solutions, BYOD solutions and wearables. In his role at ICON, he was at the forefront of the SaaS movement for clinical app development where he was instrumental in building an industry-leading eCOA team of project managers that spans the US, UK and Germany.Message Presenter
Who Should Attend?
- Chief Development Officers
- Data Managers
- Operational Directors
- Clinical Development Directors
- Clinical Operations
- Commercial and Sales
- Chief Medical Officers
- Clinical Development Managers
What You Will Learn
- Maintaining continuity and improving the trial experience during the pandemic with DCT solutions
- Reducing the burden of participation and data collection in a global patient support ecosystem
- Managing disparate data sources to create actionable patient signals
- Optimizing trial workflows in an evolving landscape with essential elements of a decentralized clinical trial
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Employing over 21,000 people worldwide, we are the world’s most comprehensive CRO, dedicated to improving health and improving lives.
Covance is a global leader in nonclinical safety assessment, clinical trial testing and clinical trial management services. Our unique perspectives are based on decades of scientific, medical, and regulatory expertise. We generate more safety and efficacy data to support drug approvals than any other company, supporting our clients’ complete lifecycle management.
Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions. Visit us at www.covance.com.